仟源醫藥(300254.SZ)回覆深交所關注函:不存在利用自願性信披迎合市場熱點炒作股價情形
格隆匯2月24日丨仟源醫藥(300254.SZ)2月24日早間回覆深交所關注函稱,嘉逸醫藥與老撾聯合藥業簽署的《委託加工合作協議》屬於雙方合作意願和基本原則的框架性約定,該合作協議未設置強制約束力和違約條款,具體合作事宜存在不確定性。另外,目前老撾聯合藥業尚未取得老撾藥品監管部門關於該次委託加工合作的許可或備案,未來能否取得、何時取得許可或備案存在不確定性。
公司自願披露上述事項是基於嘉逸醫藥與老撾聯合藥業雙方簽署《委託加工合作協議》後,需分別向所在地藥品監管部門申請藥品物質實體委託生產事項的許可/備案,實質推進委託加工生產業務的合作,在推進過程中難以做到保密。公司不存在利用自願性信息披露迎合市場熱點炒作股價的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.